Rui Li

Immunotherapeutic Significance of a Prognostic Alternative Splicing Signature in Bladder Cancer

Ruirong Tan, Jiang Chen, Guanlin Wu, 2022, Technology in cancer research & treatment.

FBXL2 counteracts Grp94 to destabilize EGFR and inhibit EGFR-driven NSCLC growth

Yuhuang Li, Zhonghan Li, Jian Yang, 2021, Nature Communications.

TTPAL promotes colorectal tumorigenesis by stabilizing TRIP6 to activate Wnt/β-catenin signaling.

Jun Yu, J. Ji, J. Tong, 2019, Cancer research.

HER2 Upregulates ATF4 to Promote Cell Migration via Activation of ZEB1 and Downregulation of E-Cadherin

Z. Xiao, Peng Zeng, Hu Chen, 2019, International journal of molecular sciences.